The role of Pap smear in the diagnostics of endocervical adenocarcinoma. Issue 4 (2nd February 2021)

• Record Type: Journal Article
• Authors: Pulkkinen, Johanna; Huhtala, Heini; Kholová, Ivana
• Is Part Of: Apmis. Volume 129:Issue 4(2021)
• Page Start: 195
• Page End: 203
• Publication Date: 2021-02-02
• Subjects: Endocervical adenocarcinoma -- AIS -- pap smear -- cytological features -- HPV -- pathology; Pathology -- Periodicals; Microbiology -- Periodicals; Immunology -- Periodicals; 572
• DOI: 10.1111/apm.13115
• Languages: English
• ISSNs: 0903-4641

Abstract

Abstract : In the high‐income countries, the amount of cervical adenocarcinomas is on the rise. The pap smear sampling has a low sensitivity and a low specificity for endocervical malignancies, and there are only a few cytomorphological features, that are specifically associated with glandular atypia. In this study, 298 pap smears of 60 patients with endocervical adenocarcinoma or adenocarcinoma in situ (AIS) and 30 patients with high‐grade intraepithelial lesion (HSIL) in histology were reviewed. The pap smear type (screening/clinical), the HPV status and the time from sampling to the histological confirmation of diagnosis were recorded for each case. Despite that no cytomorphological features could be associated with adenocarcinoma statistically, 70% of the pap smears were initially correctly diagnosed as an endocervical glandular lesion. Palisading cell borders, nuclear pleomorphism and the lack of single atypical cells present simultaneously were found to be associated with adenocarcinoma and AIS with the corresponding ORs of 5.89 (95% CI 1.96–17.70), 3.71 (95% CI 1.14–12.02) and 10.76 (95% CI 1.20–59.50). This combination of features was seen in smears taken up to 5 years before the histological diagnosis. Of all our screening samples, 10.9% were HPV‐positive. There were no HPV‐negative samples among patients with adenocarcinoma.